Expert insights. Personalized for you.
Laboratory tests indicated the biotech's shot would still protect against virus variants detected in the U.K. and South Africa, although the latter appeared to result in a weaker immune response MORE
Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group THOUSAND OAKS, Calif. & MORE
The results show that drugs from both companies can help prevent or treat COVID-19 when given at the right time. But that won't mean much if barriers to use remain high MORE
A twist on the decade’s-old design improves blood flow, prevents clots Credit: UBCO New research coming out of UBC’s Okanagan campus may take the current ‘gold standard’ for heart valves to a new level of reliability. MORE
Project managers in the biotech industry play an especially important role on a daily basis MORE
San Diego’s IconOVir Bio has raised $77 million in Series A financing to develop differentiated oncolytic virus candidates which the company believes could be tumor-selective to infect and destroy tumor cells. The financing was co-led by Nextech and Vida Ventures. MORE
The COVID-19 pandemic has changed working life around the world, with lockdowns forcing millions to work remotely while balancing their home and child-care responsibilities. However, many types of work cannot be completed remotely, including medical care, food service and transportation. MORE
Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM. MORE
The World Health Organizationâs Global Advisory Committee on Vaccine Safety says it has not seen any unexpected or untoward increase in fatalities in frail and elderly individuals who have received the Pfizer/BioNTech vaccine. Markets & Regulations MORE
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared. Antibodies Drugs (Pharmaceuticals) Nursing Homes Disease Rates Elderly Coronavirus (2019-nCoV) Vaccination and Immunization Elder Care Deaths (Fatalities) Eli Lilly and Company United States MORE
Thanks to food delivery apps, ordering food is just a few taps or a phone call away. But when it arrives, the quality of the food doesn’t always match up to that of dining in — perhaps that salad is slightly soggy or those fries have lost some of their crunch. MORE
Credit: William Precht By 2020, massive losses of large populations of corals have been observed throughout Florida and into the greater Caribbean basin. MORE
SUMMARY: Digital is a way of thinking; it’s not a tactic. To many going digital can mean a ton of opportunities but if you move too quickly you can lose sight of the end goal. Is your organization digital ready? MORE
The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. MORE
It’s 2021 – Happy New Year to you and yours. The change of the calendar from December 31 to January 1 is a symbolic milestone for a new start, a clean slate, to turn over a new leaf, (insert your saying here). This year is no different. MORE
GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung cancer drug last week. MORE
Credit: Jan Zrimec/Chalmers University of Technology Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. MORE
It’s no secret that food delivery usage has skyrocketed over the course of the pandemic. With stay-at-home orders and strict guidelines for restaurants, many have turned to food delivery to fulfill cravings, and restaurants that have managed to survive so far have used it as a lifeline. MORE
Rather than a once-a-day pill, Cabenuva comes as a once-a-month injection. That convenience could become a valuable tool for GSK as it tries to broaden adoption of two-drug treatments MORE
The European Ombudsman is investigating the secrecy with which the EU executive is handling COVID-19 vaccine supply contracts. Markets & Regulations MORE
BioNTech's CEO has also promised data will soon be available on the shot's protection against a South African variant that's worried public health experts MORE
Roche announced topline data from two identical Phase III trials, TENAYA and LUCERNE, of faricimab in neovascular or “wet” age-related macular degeneration (nAMD MORE
Waste clearance is crucial for brain health, preventing neurodegenerative disease Credit: Ravi Allada/Northwestern University A new Northwestern University study reaffirms the importance of getting a good night’s sleep. MORE
Merck is shutting down the programs linked to its two COVID-19 vaccine candidates following early trial data indicating that they failed to generate immune responses comparable to a natural infection or existing vaccines. Bio Developments MORE
An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient MORE
AstraZeneca along with its scientific partners at the University of Oxford have rejected German media reports that their vaccine against COVID-19 had low efficacy in people aged over 65. Markets & Regulations MORE
Katherine High and Jude Samulski, two well-known gene therapy researchers, were longtime collaborators and competitors. Now they're colleagues at one of the world's largest drugmakers MORE
SUMMARY: The LinkedIn team had a unique take on measuring ROI. “77% of marketers measure ROI within the first month of their campaign, knowingly trying to “prove ROI in a shorter amount of time than their typical sales cycle., MORE
After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose. MORE
Lupkynis, the first oral drug approved for lupus nephritis, comes with a high list price. Its developer, Aurinia Pharmaceuticals, expects average net revenue of roughly $65,000 per patient per year MORE
The U.S. Food and Drug Administration gave the green light to Aurinia’s Lupkynis (voclosporin) in combination with a background immunosuppressive therapy regimen for LN MORE
The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials MORE
SUMMARY: Among US adults who looked for health information and used the internet for their most recent search, the percentage who reported accessing health information without frustration was stable during the study period (from 37.2% in 2008 to 38.5% in 2017). MORE
Gilead Sciences says its antiviral Veklury should be effective against the new, more contagious COVID-19 variants discovered in the UK and South Africa. MORE
Despite the rising number of COVID-19 cases reported across the globe, rates of influenza have virtually flatlined across the Northern Hemisphere, leading many doctors and researchers to wonder how this could be replicated in non-pandemic times MORE
Results from a clinical trial in nursing home residents and staff offered the first evidence Lilly's bamlanivimab could protect against, as well as treat, COVID-19 MORE
An in vitro study shows Moderna's existing mRNA COVID-19 vaccine provides protection against strains that have emerged from South Africa and the UK. MORE
Bio Pharma Dive
JANUARY 25, 2021
The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials
World of DTC Marketing
JANUARY 26, 2021
SUMMARY: Digital is a way of thinking; it’s not a tactic. To many going digital can mean a ton of opportunities but if you move too quickly you can lose sight of the end goal. Is your organization digital ready?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
JANUARY 25, 2021
Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM.
XTalks
JANUARY 21, 2021
It’s no secret that food delivery usage has skyrocketed over the course of the pandemic. With stay-at-home orders and strict guidelines for restaurants, many have turned to food delivery to fulfill cravings, and restaurants that have managed to survive so far have used it as a lifeline.
NY Times
JANUARY 22, 2021
After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.
Bio Pharma Dive
JANUARY 21, 2021
Katherine High and Jude Samulski, two well-known gene therapy researchers, were longtime collaborators and competitors. Now they're colleagues at one of the world's largest drugmakers
World of DTC Marketing
JANUARY 25, 2021
SUMMARY: The LinkedIn team had a unique take on measuring ROI. “77% of marketers measure ROI within the first month of their campaign, knowingly trying to “prove ROI in a shorter amount of time than their typical sales cycle.,
Clinical Research Informer brings together the best content for pharmaceutical professionals from the widest variety of industry thought leaders.
XTalks
JANUARY 20, 2021
The COVID-19 pandemic has changed working life around the world, with lockdowns forcing millions to work remotely while balancing their home and child-care responsibilities. However, many types of work cannot be completed remotely, including medical care, food service and transportation.
Delveinsight
JANUARY 22, 2021
The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market.
Bio Pharma Dive
JANUARY 25, 2021
Lupkynis, the first oral drug approved for lupus nephritis, comes with a high list price. Its developer, Aurinia Pharmaceuticals, expects average net revenue of roughly $65,000 per patient per year
World of DTC Marketing
JANUARY 21, 2021
SUMMARY: Among US adults who looked for health information and used the internet for their most recent search, the percentage who reported accessing health information without frustration was stable during the study period (from 37.2% in 2008 to 38.5% in 2017).
BioPharma Reporter
JANUARY 25, 2021
The European Ombudsman is investigating the secrecy with which the EU executive is handling COVID-19 vaccine supply contracts. Markets & Regulations
Imperical Blog
JANUARY 26, 2021
It’s 2021 – Happy New Year to you and yours. The change of the calendar from December 31 to January 1 is a symbolic milestone for a new start, a clean slate, to turn over a new leaf, (insert your saying here). This year is no different.
XTalks
JANUARY 26, 2021
Thanks to food delivery apps, ordering food is just a few taps or a phone call away. But when it arrives, the quality of the food doesn’t always match up to that of dining in — perhaps that salad is slightly soggy or those fries have lost some of their crunch.
Bio Pharma Dive
JANUARY 20, 2021
BioNTech's CEO has also promised data will soon be available on the shot's protection against a South African variant that's worried public health experts
BioSpace
JANUARY 24, 2021
Roche announced topline data from two identical Phase III trials, TENAYA and LUCERNE, of faricimab in neovascular or “wet” age-related macular degeneration (nAMD
BioPharma Reporter
JANUARY 26, 2021
AstraZeneca along with its scientific partners at the University of Oxford have rejected German media reports that their vaccine against COVID-19 had low efficacy in people aged over 65. Markets & Regulations
Pharma Phorum
JANUARY 22, 2021
Gilead Sciences says its antiviral Veklury should be effective against the new, more contagious COVID-19 variants discovered in the UK and South Africa.
Scienmag
JANUARY 20, 2021
Credit: Jan Zrimec/Chalmers University of Technology Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected.
Bio Pharma Dive
JANUARY 25, 2021
Laboratory tests indicated the biotech's shot would still protect against virus variants detected in the U.K. and South Africa, although the latter appeared to result in a weaker immune response
BioSpace
JANUARY 21, 2021
Despite the rising number of COVID-19 cases reported across the globe, rates of influenza have virtually flatlined across the Northern Hemisphere, leading many doctors and researchers to wonder how this could be replicated in non-pandemic times
BioPharma Reporter
JANUARY 22, 2021
The World Health Organizationâs Global Advisory Committee on Vaccine Safety says it has not seen any unexpected or untoward increase in fatalities in frail and elderly individuals who have received the Pfizer/BioNTech vaccine. Markets & Regulations
XTalks
JANUARY 20, 2021
San Diego’s IconOVir Bio has raised $77 million in Series A financing to develop differentiated oncolytic virus candidates which the company believes could be tumor-selective to infect and destroy tumor cells. The financing was co-led by Nextech and Vida Ventures.
Scienmag
JANUARY 20, 2021
Waste clearance is crucial for brain health, preventing neurodegenerative disease Credit: Ravi Allada/Northwestern University A new Northwestern University study reaffirms the importance of getting a good night’s sleep.
Bio Pharma Dive
JANUARY 20, 2021
Results from a clinical trial in nursing home residents and staff offered the first evidence Lilly's bamlanivimab could protect against, as well as treat, COVID-19
BioSpace
JANUARY 24, 2021
The U.S. Food and Drug Administration gave the green light to Aurinia’s Lupkynis (voclosporin) in combination with a background immunosuppressive therapy regimen for LN
BioPharma Reporter
JANUARY 25, 2021
Merck is shutting down the programs linked to its two COVID-19 vaccine candidates following early trial data indicating that they failed to generate immune responses comparable to a natural infection or existing vaccines. Bio Developments
Pharma Phorum
JANUARY 25, 2021
GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung cancer drug last week.
Scienmag
JANUARY 25, 2021
Credit: William Precht By 2020, massive losses of large populations of corals have been observed throughout Florida and into the greater Caribbean basin.
Bio Pharma Dive
JANUARY 26, 2021
The results show that drugs from both companies can help prevent or treat COVID-19 when given at the right time. But that won't mean much if barriers to use remain high
BioSpace
JANUARY 25, 2021
An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient
BioPharma Reporter
JANUARY 25, 2021
An in vitro study shows Moderna's existing mRNA COVID-19 vaccine provides protection against strains that have emerged from South Africa and the UK.
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared. Antibodies Drugs (Pharmaceuticals) Nursing Homes Disease Rates Elderly Coronavirus (2019-nCoV) Vaccination and Immunization Elder Care Deaths (Fatalities) Eli Lilly and Company United States
Scienmag
JANUARY 25, 2021
A twist on the decade’s-old design improves blood flow, prevents clots Credit: UBCO New research coming out of UBC’s Okanagan campus may take the current ‘gold standard’ for heart valves to a new level of reliability.
Bio Pharma Dive
JANUARY 22, 2021
Rather than a once-a-day pill, Cabenuva comes as a once-a-month injection. That convenience could become a valuable tool for GSK as it tries to broaden adoption of two-drug treatments
BioSpace
JANUARY 20, 2021
Protecting the most vulnerable, Eli Lilly’s bamlanivimab significantly reduced COVID-19 risk for nursing home residents in a Phase III trial
BioTech 365
JANUARY 26, 2021
Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group THOUSAND OAKS, Calif. &
179 
Let's personalize your content